Concert persuades FDA to keep breakthrough tag for alopecia therapy despite Lilly's arrival

Concert Pharmaceuticals managed to keep hold of the breakthrough tag for its alopecia areata therapy, even though the approval of Eli Lilly’s rival gave the FDA second thoughts.